Fingerprint
Dive into the research topics of 'A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal ® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically